China Traditional Chinese Medicine Possible Privatisation
Sinopharm Hongkong, the controlling shareholder, is currently exploring a privatisation proposal. At the last close price, the downside risk is low...
707 Views
Trad Chi Med (570 HK): Sinopharm's Feverish Proposal
Share currently suspended, so there's nothing to be done as such. The insight is labeled bullish as an Offer appears forthcoming.
672 Views
Beijing Tong Ren Tang Chinese Medicine: A Turnaround Worth A Look
Beijing Tong Ren Tang Chinese Medicine can be a rare turnaround case in our opinion, thanks to its wide moat and compounding capability.
718 Views
Shanghai/​​Shenzhen Connect Ideas: $3 Bn Inflows, $168 Bn of Holdings (2019-09-20)
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
810 Views